Veracyte Inc

Veracyte Inc

VCYT

Get informed when a big investor buys or sells

+ Follow
Market Cap$3.47B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Veracyte IncVeracyte Inc29.9-8%6.6-
$57.50

Target Price by Analysts

24.9% upsideVeracyte Target Price DetailsTarget Price
$39.12

Current Fair Value

15% downside

Overvalued by 15% based on the discounted cash flow analysis.

Share Statistics

Market cap$3.47 Billion
Enterprise Value$3.21 Billion
Dividend Yield$- (-)
Earnings per Share$0.84
Beta1.95
Outstanding Shares79,656,250

Return

Return on Equity8.25%ROE
Return on Assets7.70%
Return on Invested Capital7.45%

Valuation & Multiples

P/E Ratio29.94P/E Ratio
PEG-1.11PEG
Price to Sales6.58Price to Sales
Price to Book Ratio2.71Price to Book Ratio
Enterprise Value to Revenue5.71
Enterprise Value to EBIT30.25
Enterprise Value to Net Income28
Total Debt to Enterprise0.01
Debt to Equity0.03Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 5, 2026
EPS Estimate
$0.44
Average shareholder expectation
Revenue Estimate
$144.56 M
Average shareholder expectation

Next Earnings Call

Expected Date
November 3, 2026
EPS Estimate
$0.41
Average shareholder expectation
Revenue Estimate
$147.16 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.0000▼ 17.12%
Total Calls-▼ 100.00%
Total Puts-▼ 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %3.40%▼ 109.69%
Total Invested$124.71M▼ 97.64%
Investors Holding23▼ 356.00%

ESG Score

No data

About Veracyte Inc

CEO: Bonnie Anderson